Literature DB >> 3322905

Effects of hypoglycaemia on early embryogenesis in rat embryo organ culture.

S Akazawa1, M Akazawa, M Hashimoto, Y Yamaguchi, N Kuriya, K Toyama, Y Ueda, T Nakanishi, T Mori, S Miyake.   

Abstract

As congenital malformations may be caused by perturbations of glycolytic flux on early embryogenesis [16], effects of hypoglycaemia were investigated by using rat embryo organ culture. Nine and one-half day old rat embryos were grown in vitro for 48 h (day 9 1/2 to 11 1/2) in the presence of hypoglycaemic serum for different hours during the culture period. Hypoglycaemic serum was obtained from rats given insulin intraperitoneally. On exposure to hypoglycaemic serum during the first 24 h of culture (day 9 1/2 to 10 1/2), embryos showed marked growth retardation and had increased frequencies of neural lesions (42.7% versus 0%, p less than 0.01), in contrast to hypoglycaemic exposure during the second 24 h of culture (day 10 1/2 to 11 1/2), where only minor growth retardation and low frequencies of neural lesions (2.4% versus 0%, NS) were seen. Even exposure to hypoglycaemic serum for a relatively short period (8 h) during the first 24 h of culture resulted in neural lesions at the frequency of 9.3-13.3%. The embryos exposed to hypoglycaemia demonstrated decreased glucose uptake and lactic acid formation, indicating decreased energy production via glycolysis that constitutes the principal energy pathway at this stage of embryonic development. These results suggest that hypoglycaemia during critical periods of embryogenesis has adverse effects on the development of the embryo and these effects might be mediated through metabolic interruption of embryogenesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3322905     DOI: 10.1007/BF00275745

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  30 in total

1.  Insulin receptors in embryo and extraembryonic membranes of early somite rat conceptus.

Authors:  T Unterman; R R Goewert; G Baumann; N Freinkel
Journal:  Diabetes       Date:  1986-11       Impact factor: 9.461

2.  Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers.

Authors:  E Miller; J W Hare; J P Cloherty; P J Dunn; R E Gleason; J S Soeldner; J L Kitzmiller
Journal:  N Engl J Med       Date:  1981-05-28       Impact factor: 91.245

3.  Maternal diabetes mellitus and congenital malformation. Survey of 205 cases.

Authors:  R E Day; J Insley
Journal:  Arch Dis Child       Date:  1976-12       Impact factor: 3.791

4.  Experimental diabetes in pregnant mice. Prevention of congenital malformations in offspring by insulin.

Authors:  K I Horii; G I Watanabe; T H Ingalls
Journal:  Diabetes       Date:  1966-03       Impact factor: 9.461

5.  The ontogeny of epidermal growth factor receptors during mouse development.

Authors:  E D Adamson; J Meek
Journal:  Dev Biol       Date:  1984-05       Impact factor: 3.582

6.  Somatomedin inhibitors from diabetic rat serum alter growth and development of mouse embryos in culture.

Authors:  T W Sadler; L S Phillips; W Balkan; S Goldstein
Journal:  Diabetes       Date:  1986-08       Impact factor: 9.461

7.  Effects of maternal diabetes on early embryogenesis. Alterations in morphogenesis produced by the ketone body, B-hydroxybutyrate.

Authors:  W E Horton; T W Sadler
Journal:  Diabetes       Date:  1983-07       Impact factor: 9.461

8.  Malformations in infants of diabetic mothers.

Authors:  J L Mills
Journal:  Teratology       Date:  1982-06

9.  Effects of maternal diabetes on early embryogenesis. The role of insulin and insulin therapy.

Authors:  T W Sadler; W E Horton
Journal:  Diabetes       Date:  1983-11       Impact factor: 9.461

10.  CONGENITAL MALFORMATIONS IN NEWBORN INFANTS OF DIABETIC WOMEN. CORRELATION WITH MATERNAL DIABETIC VASCULAR COMPLICATIONS.

Authors:  L M PEDERSEN; I TYGSTRUP; J PEDERSEN
Journal:  Lancet       Date:  1964-05-23       Impact factor: 79.321

View more
  8 in total

1.  Experimental diabetes impairs rat embryo development during the preimplantation period.

Authors:  M Vercheval; R De Hertogh; S Pampfer; I Vanderheyden; B Michiels; P De Bernardi; R De Meyer
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

Review 2.  Continuous glucose monitoring in pregnancy: new frontiers in clinical applications and research.

Authors:  Joyce F Sung; Masoud Mark Taslimi; Jeffrey C Faig
Journal:  J Diabetes Sci Technol       Date:  2012-11-01

3.  High glucose concentration inhibits migration of rat cranial neural crest cells in vitro.

Authors:  N Suzuki; K Svensson; U J Eriksson
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

4.  Glucose transporter gene expression in rat conceptus during early organogenesis and exposure to insulin-induced hypoglycemic serum.

Authors:  Y Maeda; S Akazawa; M Akazawa; Y Takao; R A Trocino; H Takino; E Kawasaki; A Yokota; S Okuno; S Nagataki
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

5.  Can prepregnancy care of diabetic women reduce the risk of abnormal babies?

Authors:  J M Steel; F D Johnstone; D A Hepburn; A F Smith
Journal:  BMJ       Date:  1990-11-10

6.  Effects of hyperglycaemia on sorbitol and myo-inositol contents of cultured embryos: treatment with aldose reductase inhibitor and myo-inositol supplementation.

Authors:  M Hashimoto; S Akazawa; M Akazawa; M Akashi; H Yamamoto; Y Maeda; Y Yamaguchi; H Yamasaki; D Tahara; T Nakanishi
Journal:  Diabetologia       Date:  1990-10       Impact factor: 10.122

7.  Glucose transporter gene expression in rat conceptus during high glucose culture.

Authors:  Y Takao; S Akazawa; K Matsumoto; H Takino; M Akazawa; R A Trocino; Y Maeda; S Okuno; E Kawasaki; S Uotani
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

8.  Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro.

Authors:  U J Eriksson; L A Borg
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.